Order Article Reprints

Le HL, Bouwhuis N, Hollak CEM, Wilhelm AJ, Gerards A-LE, Bijleveld YA, Swart EL. Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3. Pharmaceutics. 2025; 17(4):417. https://doi.org/10.3390/pharmaceutics17040417

Le, Hoang Lan, Natalja Bouwhuis, Carla E. M. Hollak, Abraham J. Wilhelm, Anne-Loes E. Gerards, Yuma A. Bijleveld, and Eleonora L. Swart. 2025. "Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3" Pharmaceutics 17, no. 4: 417. https://doi.org/10.3390/pharmaceutics17040417

Le, H. L., Bouwhuis, N., Hollak, C. E. M., Wilhelm, A. J., Gerards, A.-L. E., Bijleveld, Y. A., & Swart, E. L. (2025). Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3. Pharmaceutics, 17(4), 417. https://doi.org/10.3390/pharmaceutics17040417